MAchine Learning to Boost the Early Diagnosis of Acute Cardiovascular Conditions
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Apr 7, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the way doctors quickly diagnose serious heart problems, specifically conditions like heart attacks. Researchers are using a technique called machine learning, which helps computers analyze data, to create tools that can assist doctors in making faster and more accurate diagnoses for patients who come to the emergency department with chest pain or difficulty breathing. The main goal is to help doctors make better decisions, manage patients more quickly, and reduce mistakes in treatment.
To be part of this study, participants need to be adults aged 18 and older who are experiencing acute cardiovascular disease, which means they have sudden heart issues. Unfortunately, people who are critically ill, such as those in severe heart failure or on dialysis, cannot join. If eligible, participants will likely undergo some tests and assessments as part of the study to help researchers understand how well these new tools work in real-life situations. This trial is currently recruiting participants, and everyone's contribution could help improve emergency care for heart conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Acute cardiovascular disease (ACVD)
- • Exclusion Criteria
- • age \< 18 years old
- • patients presenting in cardiogenic shock
- • chronic terminal kidney failure requiring dialysis
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Christian Müller, Prof. Dr. med.
Study Director
University Hospital, Basel, Switzerland
Jasper Boeddinghaus, PD Dr. med.
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported